US3807958A - A bubble oxygenerator including a blood foam return exchanger device - Google Patents

A bubble oxygenerator including a blood foam return exchanger device Download PDF

Info

Publication number
US3807958A
US3807958A US00259713A US25971372A US3807958A US 3807958 A US3807958 A US 3807958A US 00259713 A US00259713 A US 00259713A US 25971372 A US25971372 A US 25971372A US 3807958 A US3807958 A US 3807958A
Authority
US
United States
Prior art keywords
blood
return
case
exchanger
foam
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US00259713A
Inventor
R Brumfield
E Simmons
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HARVEY RES CORP WILLIAM
WILLIAM HARVEY RES CORP US
Original Assignee
HARVEY RES CORP WILLIAM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HARVEY RES CORP WILLIAM filed Critical HARVEY RES CORP WILLIAM
Priority to US00259713A priority Critical patent/US3807958A/en
Application granted granted Critical
Publication of US3807958A publication Critical patent/US3807958A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/32Oxygenators without membranes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/32Oxygenators without membranes
    • A61M1/322Antifoam; Defoaming
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3621Extra-corporeal blood circuits
    • A61M1/3623Means for actively controlling temperature of blood
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D63/00Apparatus in general for separation processes using semi-permeable membranes
    • B01D63/06Tubular membrane modules
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D63/00Apparatus in general for separation processes using semi-permeable membranes
    • B01D63/06Tubular membrane modules
    • B01D63/069Tubular membrane modules comprising a bundle of tubular membranes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/369Temperature treatment
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S128/00Surgery
    • Y10S128/03Heart-lung

Definitions

  • a blood foam return exchanger device provides multiple fluid flow guidance channels disposed around the exterior of a blood-oxygen fluid exchanger having multiple oxygenator tubes.
  • the guidance channels formed'by multiple fins disposed parallel to the tubular axis of symmetry'of the fluid exchanger, provide additional residence time in the fluid flow channels for the gaseous exchange of the oxygen gas-blood twophase mixture while descending the channels.
  • the return shell has a return cap terminus disposed a spaced holding chamber volume above the top header plate of the exchanger, turning the blood foam flow downward 180 after ascending the oxygenator tubes.
  • the multiple fins can provide heat exchange surfaces for further precise temperature control of the blood foam.
  • the blood foam exiting from the return exchanger device flows through the surrounding defoamer filter, separating foam into blood and exchanged gases.
  • a relatively short fluid exchanger utilizes the additional blood foam residence time provided by the guidance channels.
  • Still another blood foam return exchanger device has an integral 180 U-bend return loop extension on each oxygenator tube of the fluid exchanger, and an oxygenator tube return length interiorly extending adjacently down the internal perimeter of the heat exchanger boundary case. Each exit terminus of an oxygenator tube retum length extends through the exchanger boundary case, providing an exit for the blood foam into and through the surrounding annular defoamer filter.
  • Blood oxygenators and blood temperature controllers useful for oxygenating patients blood in extracorporeal circulation are classified in Class 23 Subclass 25.8.5 The improvement taught in this invention is also so classified.
  • Fuson in U.S. Pat. No. 3,064,649, issued Nov. 20, 1962, discloses a blood filter and a separate heat exchanger apparatus for use with extra-corporeal blood circulating apparatus.
  • the mechanically separate heat exchanger and blood filter are serially connected.
  • the heat exchanger is taught for the induction of hypothermia, a conventional separate oxygenator being disclosed in the specification.
  • thermostabilizer for an extra-corporeal oxygenator of blood.
  • a separate conventional blood oxygenator system is disclosed providing for the oxygenation of the blood, and a separate individual heat exchanger is taught for the thermostabilization of the blood temperature.
  • the subject invention teaches a blood foam return exchanger device for an integral blood oxygenator and heat exchanger, providing a relatively short fluid exchanger providing the required blood foam residence time. Additionally, the device provides concurrent heat transfer agent flow useful for temperature control in the fluid exchanger, and counter-current heat flow in the blood foam return exchanger device, for precise temperature control of the blood during extracorporeal circulation.
  • a blood foam return exchanger device disposed on an integral blood oxygenator and heat exchanger combination operationally insures that extra-corporeal blood is circulated, oxygenated and concurrently precisely temperature controlled prior to return to a patients body.
  • a cross-reference application Ser. No. 240,054 filed Mar. 31, 1972, and other earlier filed extra-corporeal blood oxygenator and blood temperature controller was disclosed and taught, havinga patterned array of multiple small diameter, equal length oxygenator tubes disposed in a top and bottom pair of fluid impervious header plates, in a fluid exchanger configuration.
  • a tubular return shell provides multiple fluid flow guidance channels disposed around the exterior of a blood-oxygen fluid exchanger having multiple oxygenator tubes.
  • the guidance channels are formed in part by multiple fins disposed parallel to the tubular axis of symmetry of the exchanger, providing additional residence time in the fluid flow channels for the gaseous exchange between oxygen gas-blood two-phase mixture while descending the guidance channels.
  • the return shell has a return cap terminus disposed a spaced holding chamber volume above the top header plate of the exchanger, turning the blood foam flow downward after ascending the oxygenator tubes.
  • Themultiple fins provide additional heat exchange surfaces for further precise temperature control of the blood foam.
  • the blood foam exiting from the return exchanger device flows through the surrounding defoamer filter, separating foam into blood fluid and exchanged gases.
  • a relatively short fluid exchanger utilizes the additional blood foam residence time provided by the guidance channels.
  • the tubular heat exchanger boundary case can have multiple fluid flow guidance fins linearly integrally disposed on the case exterior, parallel to the case tubular axis of symmetry and encircling the exterior case perimeter.
  • the multiple guidance fins can have fin lengths extending from the top header plate to the multiple fin exit terminus, in part forming the multiple fluid flow guidance channels.
  • a tubular return shell can have multiple fluid flow guidance channels interiorly disposed on the tubular shell wall, the guidance channels being disposed between adjacent pairs of fins integrally secured to the tubular shell parallel to the tubular axis of symmetry of the shell.
  • the encircling fins are disposed contiguous to the exterior of the exchanger tubular boundary case.
  • the tubular return shell has a cap terminus disposed above a spaced holding chamber above the top header plate.
  • Another blood foam return device has an oxygenator tube 180 return loop extension of each fluid exchanger oxygenator tube and an oxygenator tube return length interiorly extending adjacently downward the internal perimeter of the tubular boundary case.
  • An exit terminus on each return length imperviously extends through the boundary case, providing an exit for the blood foam into and through the surrounding annular defoamer filter.
  • the U-bend exchanger tubes are temperature controlled by water or other heat transfer fluid circulating through the exchanger case.
  • FIG. 1 is an elevational perspective partial sectional view of the blood foam return exchanger device.
  • FIG. 2 is another elevational perspective partial sectional view of an additional modification of the blood foam return exchanger device.
  • FIG. 3 is an elevation perspective partial sectional view of a portion of the integral blood oxygenator and heat exchanger disclosed and taught in the cited prior patent application, Ser. No. 240,054, including the modification of the blood foam return exchanger device shown in FIG. 1.
  • FIG. 4 is a sectional view through 44 of FIG. 3.
  • FIG. 5A is an enlarged sectional fragmentary view similar to the view of FIG. 4, illustrating the configuration of the blood foam return exchanger device of FIG. 1.
  • FIG. 5B is a similar sectional view of the blood foam return exchanger device illustrated in FIG. 2.
  • FIG. 6 is an elevational perspective partial sectional view through another modification of the blood foam return exchanger device.
  • FIG. 7 is a sectional view through 77 of FIG. 6.
  • FIG. 1 A blood foam return exchanger device 10 is shown in FIG. 1 in elevational perspective view and discloses in part teachings incorporated in Ser. No. 240,054 and earlier cross-referenced patent applications.
  • Multiple, small diameter oxygenator tubes 1 1 are shown in a patterned tubular array 12, whose length 13 has a base terminus 14 and a top terminus 15.
  • a top and bottom pair of fluid impervious header plates 16 and 17 respectively secure the multiple tubes 11 in a tubular heat exchanger boundary case 18.
  • the header plates 16 and 17 are secured in the case interior in a fluid exchange configuration.
  • the tubular boundary case 18 has multiple fluid flow guidance fins l9 linearly disposed on the exterior of case 18 parallel to the case tubular axis of symmetry 36.
  • the multiple guidance fins 19 are integrally secured to the tubular boundary case 18 on the exterior case perimeter.
  • the multiple fins- 19 have fin lengths extending from the top header plate 17 substantially to the multiple blood foam exit terminus 26, providing an additional blood foam residence time between the multiple fins 19, for completion of blood oxygenation at a required blood flow rate.
  • the return shell 20 adjacently closely fits exteriorly around and over the multiple guidance fins 19, the shell 20 having a shell length 27, completing the multiple blood foam exit terminus 26.
  • the return shell 20 has a cap terminus 28 disposed above a spaced holding chamber volume 21, above the top header plate 17. Multiple fluid flow guidance channels 37 are thus provided by and between adjacent pairs of the fluid flow control fins l9 and the return shell 20.
  • a two-phase mixture of oxygen and blood is formed and introduced into the base of the oxygenator tubes 11.
  • the blood 22 and the oxygen 23 form a two-phase blood foam mixture ascending the tubes 11 and flow into the spaced holding chamber 21.
  • the return shell cap terminus 28 turns the blood foam flow downward and the blood foam 24 descends the multiple fluid flow guidance channels 37 in the flow direction indicated by the arrows 25.
  • the defoamed blood 29 is filtered through the annular defoamer filter 30 and the exchanged gas 32, containing carbon dioxide, residual oxygen, and the like, exits through the upper section of the defoamer filter 30.
  • Two filter tie cords 33 and 38 are shown securing the lower and upper terminus respectively of the filter 30, to the tubular case 18.
  • the heat transfer fluid inlet conduit 34 introduces the heat transfer fluid, typically water, and the heat transfer fluid outlet conduit 35 conducts the temperature controlled heat transfer fluid out of the device 10.
  • FIG. 2 illustrates in detail another exchanger device modification, the blood foam return exchanger device 40.
  • Multiple, small diameter oxygenator tubes 41 are shown secured in a patterned tubular array 42, having the length 43, a base terminus 44 and a top terminus 45.
  • the base header plate 46 and the top header plate 47 secure the tubular array 42 of oxygenator tubes 41 in the tubular boundary case 48.
  • a return shell 49 has multiple fluid flow guidance channels 50 interiorly disposed in the tubular return shell 49 wall.
  • the multiple corrugated fins 51 disposed in adjacent corrugated fin pairs provide the guidance control channels 50.
  • the tubular shell corrugated fins 51 are disposed parallel to the tubular axis of symmetry 61 of the shell, the fins 51 circumferentially disposed contiguous to the exterior of the tubular boundary case 48.
  • the return shell 49 has a shell length 58.
  • the shell cap terminus 59 is disposed above a spaced holding chamber volume 52, which is disposed above the top header plate 47, between the plate 47 and the cap 59.
  • the multiple fin length can extend from the return shell terminus 57 upward to the cap terminus 59, or can terminate at the top terminus 45 of the fluid exchanger top header plate 47.
  • the two-phase mixture of blood 53 and oxygen 54 illustrated schematically in FIG. 2 form a two-phase mixture which flows in the noted direction up the multiple oxygenator tubes 41, exiting into the return chamber volume 52 as the blood foam 55.
  • the blood foam 55'then returns downward along the paths denoted by the arrows 56 through the multiple fluid flow guidance channels 50, exiting from the channels at the foam blood exit terminus 60.
  • the blood then exits into an annular defoamer filter similar to the filter 30 of FIG. 1, but not shown in FIG. 2.
  • the heat transfer fluid inlet conduit 62 and exit conduit 63 respectively corresponding to the conduits 34 and 35, are also illustrated in FIG. 2.
  • FIGS. 5A and 5B separately illustrate further modifications of the return shell 49 of FIG. 2.
  • FIG. 5A illustrates the multiple oxygenator tubes 41 disposed in the interior of the tubular heat exchanger boundary case 48.
  • the tubular return shell 49 is shown to have multiple corrugations therein providing multiple fluid flow guidance channels 50 interiorly disposed in the return shell 49 between the pair of fins 51, which are formed by narrow corrugations in the ,wall 49.
  • the fins 51 are formed by narrow corrugation apertures 67 which face outwardly from the wall 48 and channels 50 which face inwardly toward the wall 48.
  • the inward facing channels 50 are the fluid flow guidance channels 50 for the flow of the two-phase mixture of bloodfoam.
  • the wall of the return shell 49' is shown to have integral solid fins 66 secured to the wall 65, fins 66 extending toward the tubular boundary case 48.
  • a close fit can be provided between the fins 66 and the wall 48 providing controlled flow of blood foam in the guidance channels 50'.
  • the blood foam return exchangerdevice illustrated in one modification 10 in FIG. 1, and a second modifi-v cation 40 in FIG. 2, FIG. 5A and FIG. 5B, can be formed of plastic material which is physiologically compatible with blood, from metal compatible-with blood, and from non-toxic metal coated with an organic composition coating compatible with blood.
  • the tubular boundary case 18 having multiple integral fluid flow control fins 19 can typically be a blood compatible plastic, or a metal structure coated with a blood compatible organic composition coating.
  • a metal structure, coated with a thin organic coating, 0.001-0002 inches thick, can provide a high heat transfer rate utilizing a typical water base heat transfer fluid.
  • An integral plastic structure can also be provided which can have the advantage of being easy to fabricate.
  • FIGS. 3 and 4 a portion of an extra-corporeal blood oxygenator and blood temperature controller 70 is shown having a blood foam return exchanger device operationally disposed therein.
  • the blood oxygenator and temperature controller is taught in the cross-referenced patent application Ser. No. 240,054 and earlier.
  • Multiple small diameter oxygenator tubes 71 are shown disposed in a patterned tubular array 72, having equal tube lengths 73.
  • the array has a base terminus74 and a top terminus 75, the multiple tubes 71 being secured by a base header plate 76 and a top header plate 77, the plates being secured in the heatexchanger tubular boundary case 78.
  • FIG. 1 As similarly illustrated in FIG.
  • the multiple fluid flow guidance fins 79 integrally extend in parallel from the tubular case 78.
  • the return shell 80 is shown closely fitting around the multiple fins 79, providing a holding chamber volume 81 disposed above the top header plate 77.
  • the two-phase mixture of blood. 82 and oxygen gas 83 are schematically shown entering the tubular array 72 adjacent the base header plate 76.
  • Blood foam 84 exits from the tubes 71 adjacent the top header plate 77 into the chamber volume 81.
  • the blood foam 84 flows downward the direction indicated by the arrow 85 in the multiple fluid flow guidance channels 109 to the return shell exit terminus 86 at the base of the return shell length 87.
  • the return shell cap terminus 88 provides a turning surface for the blood foam 84.
  • the filtered defoamed blood 89 exits through the defoamer filter envelope 90.
  • the exchanged carbon dioxide gas 92 including the residual oxygen gas and the like, escape through the upper portion of the foam filter envelope 90.
  • the pair of foam filter collars 93 and the pair of compression rings 94 secure the foam filter envelope and the filter cloth 91 to the heat exchanger tubular boundary base 78.
  • the oxygenated filtered blood accumulates in the blood reservoir 100.
  • the reservoir is formed by the reservoir base closure 101, the exterior, tubular case 102, and the case annular closure 105, as earlier taught in part in the application Ser. No. 240,054.
  • the filtered blood accumulatedin the reservoir 100 flows out in the direction 104 through the blood outlet conduit 103.
  • annular closure 105 is a modification of the oxygenator closure 55 of the patent application, Ser. No. 240,054. As illustrated in FIG. 3, the annular closure 105, integrally secured to the return shell cap terminus 88, provides a top closure for the device 70.
  • the return shell cap terminus 88 has an integral annular indexing flange 107 extending normally from the cap 88, with an integral vertical support ring 110 formed thereon.
  • the filter cloth 91 which is exteriorly supportively disposed on the annular blood defoamer filter 90, terminates and is secured between the support ring 110 and the compressive filter cloth retainer ring 111. Thus the upper terminus of the annular defoamer filter 90 is permanently secured in position.
  • the lower Luer syringe aperture 108 provides means for introducing medicament into the blood accumulated in the reservoir 100.
  • the aperture 106 is earlier disclosed in the above referenced patent application, providing means for the escape of exchanged gases 92 from the oxygenator device 70.
  • the heat transfer inlet conduit 95 is conductively secured to the boundary case 78, providing for the flow of the heat transfer fluid in the direction 98 into the device 70.
  • the heat transfer agent exits through the water header conduit means 97, the water outlet manifold 99 and then through the water outlet conduit 96.
  • the closure means 112 comprises the top of the oxygenator device 70, and 112 comprises in combination the cap terminus 88, the annular closure 105, the annular indexing flange 107, and the integral vertical support ring 110.
  • FIGS. 6 and 7 Still another blood foam return fluid exchanger device is illustrated in FIGS. 6 and 7 together.
  • the blood foam return exchanger device has multiple small diameter oxygenator tubes 151 disposed in a patterned tubular array 152.
  • the array 152 is similar in planar distribution to the array 72 of FIG. 3 and the like.
  • the overall length of the multiple oxygenator tubes 151 have a controlled range of tube lengths extending from 153 to 154.
  • the base 155 of the tubular array 152 has abase header plate 156, the header plate 156 being secured in the heat exchanger boundary case 157.
  • Each one of the multiple oxygenator tubes 151 has an integral return loop 158 formed in a U-bend, amounting to an angle.
  • Each return loop 158 of one multiple oxygenator tube 151 is continuously integrally joined to one return length 159 of the oxygenator tube 151.
  • the multiple return lengths 159 all terminate at substantially the same terminus line 186 level on the device 150.
  • the multiple return length 159 extend downward inside the boundary case 157 adjacent to the interior case perimeter, each one of the tubes 159 having a tube exit terminus 163 disposed downward through the case wall.
  • the tube lengths 159 are fluid imperviously sealed to the case wall.
  • the inlet blood 160 is mixed in a two-phase flow with the inlet oxygen 161 and introduced into the multiple oxygenator tubes 151 at the base header plate 156.
  • the oxygenated blood foam 162 exits from each one of the oxygenator tube.exit terminus 163.
  • the filtered defoamed blood is formed by passage through the annular blood defoamer filter combination of the annular defoamer 165 and the cloth filter 167.
  • the defoamed blood is held in the blood collection reservoir 172.
  • the annular defoamer 165 is secured by a first foam filter tie ring 166, and further secured by the cloth filter 167 which is additionally secured by the second tie ring 168.
  • the top of the foam filter 165 and cloth filter 167 combination are secured in position by the first top closure 169.
  • the first closure 169 also forms the top terminus of the heat exchanger 187.
  • the heat exchanger 187 can exchange energy with the blood foam disposed in the multiple oxygenator tubes
  • the heat exchanger 187 comprises the multiple oxygenator tubes 151, the base header plate 156, the first closure 169, the exchanger tubular boundary case 157, the water inlet conduit 176, and the water outlet conduit 179.
  • the heat transfer fluid typically water
  • the water outlet conduit 179 has an internal exchanger terminus 180.
  • the device 150 has a second top closure 182, a reservoir bottom closure 184, and an external tubular case 183, as previously disclosed.
  • the blood outlet flow 173 is through the blood outlet conduit 175.
  • the exchanged gases escape upward through the annular gas escape chamber 170 through the annular defoamer filter 165 and the cloth filter 167 into the annular aperture 174, and thence out of the device 150 through the second top closure 182 as previously taught.
  • the oxygenator component device 150 as taught above provides a further modification of the blood foam retum exchanger device, having increased blood foam residence time in the oxygenator tubes'in a compact device occupying relatively a short space and volume in a surgical operating room environment.
  • F lG. 7 illu st rates in det ail therelative positions of the multiple return loops 158 disposed in the patterned tubular array 152, which can provide for the patterned disposition of the multiple return lengths 159 of each one of the tubes 151, adjacent to the interior perimeter of the case 157.
  • the return lengths 159 are disposed in a circular array around the perimeter of the patterned tubular array 152.
  • FIG. 6 illustrates in elevational view
  • FIG. 7 illustrates in cross sectional view the positioning of the tiers of the multiple return loops 158.
  • the multiple tube exit terminus 163 are disposed exteriorly through the case 157.
  • the blood foam return exchanger device of this invention in combination with an extracorporeal blood oxygenator and blood temperature controller disclosed, taught and claimed in the crossreferenced applications, it is possible to reduce the length, typically 73 or the like, of the array of the multiple oxygenator tubes 71 or the like, since the blood foam is provided additional residence time in the blood foam return exchanger device for gas exchange. Further, the blood exchanges energy with the heat transfer fluid, such as water, as the blood foam rises in the patterned tubular array 72 or the like, and then further exchanges thermal energy as the blood foam descends in the direction or the like in the blood foam return exchanger device.
  • the heat transfer fluid such as water
  • the additional residence time in the blood foam return exchanger device can provide blood foam counter flow for further precisely adjusting the blood foam temperature to the desired value, preventing fluctuation in blood temperature, which can be very undesirable.
  • a metal fin structure can be incorporated in the blood foam return exchanger device as taught above, providing for a rapid controlled change of blood temperature, as is required.
  • the annular blood defoamer filter combination utilized with the invention filters from the bottom of the filter initially, rising toward the top of the filteras the filter pores become clogged. Thus the defoamed blood does not needlessly wash the unused filter until it is required. The filtered blood does not wet and stand in the unrequired annular foam filter.
  • the filtering of the blood foam initially at the base of the annular foam filter provides additional safety against the introduction of minute quantities of compositions which can produce undesired responses in the patient.
  • a 25 kg weight dog test animal was perfused approximately 91 minutes, utilizing the extra-corporeal blood oxygenator and blood temperature controller incorporating the blood foam return exchanger device illustrated in FIG. 2.
  • the test animal was sedated with Nembutal and cannulae bypass were inserted into the heart aorta and right atrium.
  • the oxygenator was initially primed with 1,000 ml of Ringers lactate. Additional Ringers lactate and blood were added as required during the perfusion test.
  • the essential data measuring the status of the dog are listed in Table I.
  • the test animal was successfully maintained on the oxygenator of this invention for minutes. Sustained pumped perfusion was maintained at.
  • anextra-corporeal blood oxygenator and blood temperature controller having a patterned array of multiple, small diameter, equal length oxygenator tubes disposed in a top and a bottom pair of fluid-imperviousv header plates, useful for providing a blood foam composition in said multiple oxygenator tubes, the improvement comprising a blood foam return exchanger device combination comprising:
  • tubular boundary case having a case interior, said base header plate, said top. header plate and said.
  • a blood foam composition can; be, formed in-said multiple oxygenator tubes, the. improvement comprising. a blood foam retum exchanger device combination comprising:
  • tubular case interior, said, base header plate, said top' header plate and said multiple oxygenator tubes secured in said caseinterior in a fluid exchange configuration, said tubular case having multiplelfluid flow guidance fins linearly disposedton the exterior. ofsaidboundary case parallel to the casetubular axis of symmetry and.
  • perimeter said multiple guidance fins integrally secu'red to said exterior case perimeter and having fin lengths extending from said top header plate to multiple fin exit terminuses at a predetermined distance below said top header plate;
  • a return shell adjacently' fitting exteriorly around and over said multiple guidance fins, said return shell having a shell length providing multiple blood foam exit terminuses adjacent to said multiple fin exit terminuses, said return shell having a cap terminus disposed above a spaced holding chamber volume above said top header plate,
  • said blood foam composition which can be formed in said multiple oxygenator tubes can flow into said spaced holding chamber volume, thence into the multiple fluid flow guidance channels provided between said return shell and said multiple fluid flow guidance fins and down through said multiple blood foam exit terminuses of said foam return fluid exchanger device.
  • tubular heat exchanger boundary case is formed froma non-toxic metal having a thinorganic composition coating disposed completely over the faceofsaidcase'exposed to said blood foam, said coating' being physiologically compatible with said blood foam.
  • the blood foam return exchanger device of claim 2 in-which saidretum shell is formed-from a plastic composition, physiologically .compatible with said blood foam.
  • the blood foam return exchanger device of claim 2 having an annular blood defoamer filter loosely temperaturecontroller having a patterned array of.
  • a blood foam return exchanger device combination comprising:
  • tubular heat exchanger boundary case having a case interior, said base header plate, said top header plate and said multiple oxygenator tubes secured in said case interior in a fluid exchanger configuration;
  • a tubular return shell adjacently fitting circumferentially around said fluid exchanger configuration, said return shell having multiple fluid flow guidance channels interiorly disposed on the tubular shell wall, said guidance channels disposed between adjacent pairs of fins integrally secured to said tubular shell parallel to the tubular axis of symmetry of said shell, said fins encirclingly disposed contiguous to the exterior of said tubular boundary case, said fins having fin lengths extending from at least said top header plate to multiple fin exit terminuses at a predetermined distance below said top header plate, said tubular return shell having a cap terminus disposed above a spaced holding chamber volume above said top header plate, said multiple fin lengthproviding a blood foam residence time between said fins for completion of blood oxygenation at a required blood flow rate and blood temperature.
  • tubular return shell is formed from a non-toxic metal having a thin organic composition coating disposed completely over the face of said shell exposed to said blood foam, said coating being physiologically compatible with said blood foam.
  • the blood foam return exchanger deviceof claim 6 having an annular blood defoamer filter loosely spaced completely circumferentially around said return changer tubular boundary case securing said header plate in the boundary case base, the improvement comprising a blood foam return exchanger device combination comprising:
  • said multiple oxygenator tubes having a controlled range of tube lengths, each one of said tubes having a U-bend at the upper extremity thereof, each one of said tubes having a return length extending downwardly inside said exchanger case adjacent to the interior perimeter of said case, each one of said tubes having a tube exit terminus disposed downwardly, through the exchanger case wall and fluid imperviously sealed to said wall, all said exit terminuses disposed at substantially the same terminus line level of said case; a closure securing the top of said heat exchanger case; means for conducting a heat transfer fluid through said heat exchanger case; an annular blood defoamer filter spaced circumferentially around said heat exchanger case and said multiple tube exit terminuses, said filter having one perimeter terminus conductively sealed to said exchanger case adjacently below said case closure, and said filter having the second perimeter terminus conductively sealed to said oxygenator below said terminus line level so that blood foam exiting from said multiple tube exit terminuses must pass through said defoamer filter.

Abstract

A blood foam return exchanger device provides multiple fluid flow guidance channels disposed around the exterior of a bloodoxygen fluid exchanger having multiple oxygenator tubes. The guidance channels, formed by multiple fins disposed parallel to the tubular axis of symmetry of the fluid exchanger, provide additional residence time in the fluid flow channels for the gaseous exchange of the oxygen gas-blood two-phase mixture while descending the channels. The return shell has a return cap terminus disposed a spaced holding chamber volume above the top header plate of the exchanger, turning the blood foam flow downward 180* after ascending the oxygenator tubes. The multiple fins can provide heat exchange surfaces for further precise temperature control of the blood foam. The blood foam exiting from the return exchanger device flows through the surrounding defoamer filter, separating foam into blood and exchanged gases. A relatively short fluid exchanger utilizes the additional blood foam residence time provided by the guidance channels. Still another blood foam return exchanger device has an integral 180* U-bend return loop extension on each oxygenator tube of the fluid exchanger, and an oxygenator tube return length interiorly extending adjacently down the internal perimeter of the heat exchanger boundary case. Each exit terminus of an oxygenator tube return length extends through the exchanger boundary case, providing an exit for the blood foam into and through the surrounding annular defoamer filter.

Description

United States Patent [191 Brumfield et 'al.
[111- 3,807,958 Apr. 30, 1974 1 1 A BUBBLE OXYGENERATOR INCLUDING A BLOOD FOAM RETURN EXCHANGER DEVICE [75] Inventors: RobertC. Brumfield, Laguna I Beach; Edward E. Simmons,
Pasadena, both of Calif.
[73] Assignee: William Harvey Research Corporation, Santa Ana, Calif. 22 Filed: June 5, 1972 [21] Appl. N0.: 259,713
[52] US. Cl 23/2585, 55/255, 55/256,
128/400, 128/D1G. 3, 261/122, 261/124 51 Int. 01...... A6lm 1 /03 [58] Field of Search 23/258.5; l28/DIG. 3, 400; r I 26l/l22-l28; 55/255, 256; l95/1.8
[56] References Cited UNITED STATES PATENTS 3,291,568 12/1966 Sautter 23/2585 3,488,158 1/1970 Bentley et a1... 23/2585 3,493,347 2/1970 Everett 23/2585 3,547,591 12/1970 Torres 23/2585 3,578,411 5/1971' 1 Bentley et a1... 23/2585 3,615,238 10/1971 Bentley et al... 23/2585 3,764,271 10/1973 Brumfield 23/2585 3,769,162 10/1973 Brumfield 195/1.8 3,769,163 10/1973 Brumfield 195/18 Primary Examiner-Barry S. Richman I Attorney, Agent, or Firm.l. L. Jones, Sr.
57 ABSTRACT A blood foam return exchanger device provides multiple fluid flow guidance channels disposed around the exterior of a blood-oxygen fluid exchanger having multiple oxygenator tubes. The guidance channels, formed'by multiple fins disposed parallel to the tubular axis of symmetry'of the fluid exchanger, provide additional residence time in the fluid flow channels for the gaseous exchange of the oxygen gas-blood twophase mixture while descending the channels. The return shell has a return cap terminus disposed a spaced holding chamber volume above the top header plate of the exchanger, turning the blood foam flow downward 180 after ascending the oxygenator tubes. The multiple fins can provide heat exchange surfaces for further precise temperature control of the blood foam. The blood foam exiting from the return exchanger device flows through the surrounding defoamer filter, separating foam into blood and exchanged gases. A relatively short fluid exchanger utilizes the additional blood foam residence time provided by the guidance channels. Still another blood foam return exchanger device has an integral 180 U-bend return loop extension on each oxygenator tube of the fluid exchanger, and an oxygenator tube return length interiorly extending adjacently down the internal perimeter of the heat exchanger boundary case. Each exit terminus of an oxygenator tube retum length extends through the exchanger boundary case, providing an exit for the blood foam into and through the surrounding annular defoamer filter.
10 Claims, 8 Drawing Figures- PATENTEDAPR 30 m4 3.807;.958
' SHEEI l 0F 6 v A BUBBLE OXYGENERATOR INCLUDING A BLOOD FOAM RETURN EXCHANGER DEVICE CROSS REFERENCES TO RELATED APPLICATIONS This application is related to the following applications filed earlier by the sole inventor, Robert C. Brumfield:
U.S. patent application, Ser. No. 175,182 for BLOOD OXYGENATOR AND THERMOREGU- LATOR APPARATUS, by Robert C. Brumfield, filed Aug. 26, 1971; now U.S. Pat. No. 3,769,162;
U.S. patent application, Ser. No. 196,458 for BLOOD OXYGENATOR FLOW GUIDE, by Robert C. Brumfield, filed Nov. 11, 1971; now U.S. Pat. No. 3,769,163;
U.S. patent application, Ser. No. 202,779 for TWO- PHASE FLUID FLOW GUIDE FOR BLOOD OXY- GENATOR, by Robert C. Brumfield, filed Nov. 29, 1971', now U.S. Pat. No. 3,770,384;
U.S. patent application, Ser. No. 216,649 for LOW PRESSURE HEAT EXCHANGER FOR OXYGEN- ATED BLOOD, by Robert C. Brumfield, filed Jan. 10, 1972; now U.S. Pat. No. 3,764,271; and the application by the co-inventors,
U.S. patent application, Ser. No. 240,054 for INTE- GRAL BLOOD OXYGENATOR AND HEAT EX- CHANGER, by Robert C. Brumfield and Alton V. Hooper, filed Mar. 31, 1972; now U.S. Pat. No. 3,768,977, and assigned to Robert C. Brumfield.
BACKGROUND OF THE INVENTION Blood oxygenators and blood temperature controllers useful for oxygenating patients blood in extracorporeal circulation are classified in Class 23 Subclass 25.8.5 The improvement taught in this invention is also so classified.
Fuson, in U.S. Pat. No. 3,064,649, issued Nov. 20, 1962, discloses a blood filter and a separate heat exchanger apparatus for use with extra-corporeal blood circulating apparatus. The mechanically separate heat exchanger and blood filter are serially connected. The heat exchanger is taught for the induction of hypothermia, a conventional separate oxygenator being disclosed in the specification.
DeWall in U.S. Pat. No. 3,256,883, issued June 21, 1966, discloses atwo dimensional envelope or bag-type oxygenator comprised in large part of thermoplastic resinous sheet material sealed together. The temperature control or heat exchanger means shown is 'in the formof a channeled internal water jacket, which is heat sealed between walls of the oxygenator in the vicinity of multiple blood channels or conduits, warming or cooling the blood as it passes through those channels. Specifically, this invention teachesthe first step of oxygenating the blood at a relatively uncontrolled blood temperature, and then effectively controlling the blood temperature in a' second step by circulating the blood through a heat exchanger.
Claff et al. in U.S. Pat. No. 3,332,746, issued July 25, 1967, discloses a pulsatile membrane apparatus for oxygenating blood, disclosing a separate heat exchange fluid source which circulates through the oxygenator. Grooved metal plates in combination with the externally pumped heat exchange fluid provide a heat transfer energy input or output source for the blood circulating in the oxygenator. The oxygenation of the blood proceeds by diffusion through a suitable membrane.
Farrant, in U.S. Pat. No. 3,374,066, issued Mar. 19, 1968, teaches a separately operable thermostabilizer for an extra-corporeal oxygenator of blood. A separate conventional blood oxygenator system is disclosed providing for the oxygenation of the blood, and a separate individual heat exchanger is taught for the thermostabilization of the blood temperature.
The subject invention teaches a blood foam return exchanger device for an integral blood oxygenator and heat exchanger, providing a relatively short fluid exchanger providing the required blood foam residence time. Additionally, the device provides concurrent heat transfer agent flow useful for temperature control in the fluid exchanger, and counter-current heat flow in the blood foam return exchanger device, for precise temperature control of the blood during extracorporeal circulation.
SUMMARY OF THE INVENTION A blood foam return exchanger device disposed on an integral blood oxygenator and heat exchanger combination operationally insures that extra-corporeal blood is circulated, oxygenated and concurrently precisely temperature controlled prior to return to a patients body. In the cross-reference application Ser. No. 240,054, filed Mar. 31, 1972, and other earlier filed extra-corporeal blood oxygenator and blood temperature controller was disclosed and taught, havinga patterned array of multiple small diameter, equal length oxygenator tubes disposed in a top and bottom pair of fluid impervious header plates, in a fluid exchanger configuration.
A tubular return shell provides multiple fluid flow guidance channels disposed around the exterior of a blood-oxygen fluid exchanger having multiple oxygenator tubes. The guidance channels are formed in part by multiple fins disposed parallel to the tubular axis of symmetry of the exchanger, providing additional residence time in the fluid flow channels for the gaseous exchange between oxygen gas-blood two-phase mixture while descending the guidance channels. The return shell has a return cap terminus disposed a spaced holding chamber volume above the top header plate of the exchanger, turning the blood foam flow downward after ascending the oxygenator tubes. Themultiple fins provide additional heat exchange surfaces for further precise temperature control of the blood foam. The blood foam exiting from the return exchanger device flows through the surrounding defoamer filter, separating foam into blood fluid and exchanged gases. A relatively short fluid exchanger utilizes the additional blood foam residence time provided by the guidance channels. The tubular heat exchanger boundary case can have multiple fluid flow guidance fins linearly integrally disposed on the case exterior, parallel to the case tubular axis of symmetry and encircling the exterior case perimeter. The multiple guidance fins can have fin lengths extending from the top header plate to the multiple fin exit terminus, in part forming the multiple fluid flow guidance channels. Alternatively, a tubular return shell can have multiple fluid flow guidance channels interiorly disposed on the tubular shell wall, the guidance channels being disposed between adjacent pairs of fins integrally secured to the tubular shell parallel to the tubular axis of symmetry of the shell. The encircling fins are disposed contiguous to the exterior of the exchanger tubular boundary case. The tubular return shell has a cap terminus disposed above a spaced holding chamber above the top header plate.
Another blood foam return device has an oxygenator tube 180 return loop extension of each fluid exchanger oxygenator tube and an oxygenator tube return length interiorly extending adjacently downward the internal perimeter of the tubular boundary case. An exit terminus on each return length imperviously extends through the boundary case, providing an exit for the blood foam into and through the surrounding annular defoamer filter. The U-bend exchanger tubes are temperature controlled by water or other heat transfer fluid circulating through the exchanger case.
Other objects and advantages of this invention are taught in the following description and claims.
BRIEF DESCRIPTION OF THE DRAWINGS A description of this invention is to be read in conjunction with the following drawings:
FIG. 1 is an elevational perspective partial sectional view of the blood foam return exchanger device.
FIG. 2 is another elevational perspective partial sectional view of an additional modification of the blood foam return exchanger device.
FIG. 3 is an elevation perspective partial sectional view of a portion of the integral blood oxygenator and heat exchanger disclosed and taught in the cited prior patent application, Ser. No. 240,054, including the modification of the blood foam return exchanger device shown in FIG. 1.
FIG. 4 is a sectional view through 44 of FIG. 3.
FIG. 5A is an enlarged sectional fragmentary view similar to the view of FIG. 4, illustrating the configuration of the blood foam return exchanger device of FIG. 1. FIG. 5B is a similar sectional view of the blood foam return exchanger device illustrated in FIG. 2.
FIG. 6 is an elevational perspective partial sectional view through another modification of the blood foam return exchanger device.
FIG. 7 is a sectional view through 77 of FIG. 6.
DESCRIPTION OF THE PREFERRED EMBODIMENT A blood foam return exchanger device 10 is shown in FIG. 1 in elevational perspective view and discloses in part teachings incorporated in Ser. No. 240,054 and earlier cross-referenced patent applications. Multiple, small diameter oxygenator tubes 1 1 are shown in a patterned tubular array 12, whose length 13 has a base terminus 14 and a top terminus 15. A top and bottom pair of fluid impervious header plates 16 and 17 respectively secure the multiple tubes 11 in a tubular heat exchanger boundary case 18. The header plates 16 and 17 are secured in the case interior in a fluid exchange configuration. The tubular boundary case 18 has multiple fluid flow guidance fins l9 linearly disposed on the exterior of case 18 parallel to the case tubular axis of symmetry 36. The multiple guidance fins 19 are integrally secured to the tubular boundary case 18 on the exterior case perimeter. The multiple fins- 19 have fin lengths extending from the top header plate 17 substantially to the multiple blood foam exit terminus 26, providing an additional blood foam residence time between the multiple fins 19, for completion of blood oxygenation at a required blood flow rate.
The return shell 20 adjacently closely fits exteriorly around and over the multiple guidance fins 19, the shell 20 having a shell length 27, completing the multiple blood foam exit terminus 26. The return shell 20 has a cap terminus 28 disposed above a spaced holding chamber volume 21, above the top header plate 17. Multiple fluid flow guidance channels 37 are thus provided by and between adjacent pairs of the fluid flow control fins l9 and the return shell 20.
As disclosed, taught and claimed in the above crossreferenced applications, a two-phase mixture of oxygen and blood is formed and introduced into the base of the oxygenator tubes 11. As schematically shown in FIG. 1, the blood 22 and the oxygen 23 form a two-phase blood foam mixture ascending the tubes 11 and flow into the spaced holding chamber 21. The return shell cap terminus 28 turns the blood foam flow downward and the blood foam 24 descends the multiple fluid flow guidance channels 37 in the flow direction indicated by the arrows 25. The defoamed blood 29 is filtered through the annular defoamer filter 30 and the exchanged gas 32, containing carbon dioxide, residual oxygen, and the like, exits through the upper section of the defoamer filter 30. Two filter tie cords 33 and 38 are shown securing the lower and upper terminus respectively of the filter 30, to the tubular case 18. As earlier disclosed in Ser. No. 240,054, the heat transfer fluid inlet conduit 34 introduces the heat transfer fluid, typically water, and the heat transfer fluid outlet conduit 35 conducts the temperature controlled heat transfer fluid out of the device 10.
FIG. 2 illustrates in detail another exchanger device modification, the blood foam return exchanger device 40. Multiple, small diameter oxygenator tubes 41 are shown secured in a patterned tubular array 42, having the length 43, a base terminus 44 and a top terminus 45. The base header plate 46 and the top header plate 47 secure the tubular array 42 of oxygenator tubes 41 in the tubular boundary case 48. A return shell 49 has multiple fluid flow guidance channels 50 interiorly disposed in the tubular return shell 49 wall. The multiple corrugated fins 51 disposed in adjacent corrugated fin pairs provide the guidance control channels 50. The tubular shell corrugated fins 51 are disposed parallel to the tubular axis of symmetry 61 of the shell, the fins 51 circumferentially disposed contiguous to the exterior of the tubular boundary case 48. The return shell 49 has a shell length 58. The shell cap terminus 59 is disposed above a spaced holding chamber volume 52, which is disposed above the top header plate 47, between the plate 47 and the cap 59. The multiple fin length can extend from the return shell terminus 57 upward to the cap terminus 59, or can terminate at the top terminus 45 of the fluid exchanger top header plate 47.
In operation, the two-phase mixture of blood 53 and oxygen 54 illustrated schematically in FIG. 2, form a two-phase mixture which flows in the noted direction up the multiple oxygenator tubes 41, exiting into the return chamber volume 52 as the blood foam 55. The blood foam 55'then returns downward along the paths denoted by the arrows 56 through the multiple fluid flow guidance channels 50, exiting from the channels at the foam blood exit terminus 60. The blood then exits into an annular defoamer filter similar to the filter 30 of FIG. 1, but not shown in FIG. 2. The heat transfer fluid inlet conduit 62 and exit conduit 63 respectively corresponding to the conduits 34 and 35, are also illustrated in FIG. 2.
FIGS. 5A and 5B separately illustrate further modifications of the return shell 49 of FIG. 2. FIG. 5A illustrates the multiple oxygenator tubes 41 disposed in the interior of the tubular heat exchanger boundary case 48. The tubular return shell 49 is shown to have multiple corrugations therein providing multiple fluid flow guidance channels 50 interiorly disposed in the return shell 49 between the pair of fins 51, which are formed by narrow corrugations in the ,wall 49. Thus the fins 51 are formed by narrow corrugation apertures 67 which face outwardly from the wall 48 and channels 50 which face inwardly toward the wall 48. The inward facing channels 50 are the fluid flow guidance channels 50 for the flow of the two-phase mixture of bloodfoam. In FIG. 5B the wall of the return shell 49' is shown to have integral solid fins 66 secured to the wall 65, fins 66 extending toward the tubular boundary case 48. A close fit can be provided between the fins 66 and the wall 48 providing controlled flow of blood foam in the guidance channels 50'.
The blood foam return exchangerdevice illustrated in one modification 10 in FIG. 1, and a second modifi-v cation 40 in FIG. 2, FIG. 5A and FIG. 5B, can be formed of plastic material which is physiologically compatible with blood, from metal compatible-with blood, and from non-toxic metal coated with an organic composition coating compatible with blood. In theblood foam return exchanger device combination illustrated in FIG. 1, the tubular boundary case 18 having multiple integral fluid flow control fins 19 can typically be a blood compatible plastic, or a metal structure coated with a blood compatible organic composition coating. A metal structure, coated with a thin organic coating, 0.001-0002 inches thick, can provide a high heat transfer rate utilizing a typical water base heat transfer fluid. An integral plastic structure can also be provided which can have the advantage of being easy to fabricate.
' Referring now to FIGS. 3 and 4 together in detail, a portion of an extra-corporeal blood oxygenator and blood temperature controller 70 is shown having a blood foam return exchanger device operationally disposed therein. The blood oxygenator and temperature controller is taught in the cross-referenced patent application Ser. No. 240,054 and earlier. Multiple small diameter oxygenator tubes 71 are shown disposed in a patterned tubular array 72, having equal tube lengths 73. The array has a base terminus74 and a top terminus 75, the multiple tubes 71 being secured by a base header plate 76 and a top header plate 77, the plates being secured in the heatexchanger tubular boundary case 78. As similarly illustrated in FIG. 1, the multiple fluid flow guidance fins 79 integrally extend in parallel from the tubular case 78. The return shell 80 is shown closely fitting around the multiple fins 79, providing a holding chamber volume 81 disposed above the top header plate 77. The two-phase mixture of blood. 82 and oxygen gas 83 are schematically shown entering the tubular array 72 adjacent the base header plate 76. Blood foam 84 exits from the tubes 71 adjacent the top header plate 77 into the chamber volume 81. The blood foam 84 flows downward the direction indicated by the arrow 85 in the multiple fluid flow guidance channels 109 to the return shell exit terminus 86 at the base of the return shell length 87. The return shell cap terminus 88 provides a turning surface for the blood foam 84. The filtered defoamed blood 89 exits through the defoamer filter envelope 90. The exchanged carbon dioxide gas 92, including the residual oxygen gas and the like, escape through the upper portion of the foam filter envelope 90. The pair of foam filter collars 93 and the pair of compression rings 94 secure the foam filter envelope and the filter cloth 91 to the heat exchanger tubular boundary base 78. The oxygenated filtered blood accumulates in the blood reservoir 100. The reservoir is formed by the reservoir base closure 101, the exterior, tubular case 102, and the case annular closure 105, as earlier taught in part in the application Ser. No. 240,054. The filtered blood accumulatedin the reservoir 100 flows out in the direction 104 through the blood outlet conduit 103. The case annular closure 105 is a modification of the oxygenator closure 55 of the patent application, Ser. No. 240,054. As illustrated in FIG. 3, the annular closure 105, integrally secured to the return shell cap terminus 88, provides a top closure for the device 70. The return shell cap terminus 88 has an integral annular indexing flange 107 extending normally from the cap 88, with an integral vertical support ring 110 formed thereon. The filter cloth 91, which is exteriorly supportively disposed on the annular blood defoamer filter 90, terminates and is secured between the support ring 110 and the compressive filter cloth retainer ring 111. Thus the upper terminus of the annular defoamer filter 90 is permanently secured in position.
The lower Luer syringe aperture 108 provides means for introducing medicament into the blood accumulated in the reservoir 100. The aperture 106 is earlier disclosed in the above referenced patent application, providing means for the escape of exchanged gases 92 from the oxygenator device 70. As further disclosed in the earlier application, the heat transfer inlet conduit 95 is conductively secured to the boundary case 78, providing for the flow of the heat transfer fluid in the direction 98 into the device 70. The heat transfer agent exits through the water header conduit means 97, the water outlet manifold 99 and then through the water outlet conduit 96.
The closure means 112 comprises the top of the oxygenator device 70, and 112 comprises in combination the cap terminus 88, the annular closure 105, the annular indexing flange 107, and the integral vertical support ring 110.
Still another blood foam return fluid exchanger device is illustrated in FIGS. 6 and 7 together. The blood foam return exchanger device has multiple small diameter oxygenator tubes 151 disposed in a patterned tubular array 152. The array 152 is similar in planar distribution to the array 72 of FIG. 3 and the like. The overall length of the multiple oxygenator tubes 151 have a controlled range of tube lengths extending from 153 to 154. The base 155 of the tubular array 152 has abase header plate 156, the header plate 156 being secured in the heat exchanger boundary case 157. Each one of the multiple oxygenator tubes 151 has an integral return loop 158 formed in a U-bend, amounting to an angle. Each return loop 158 of one multiple oxygenator tube 151 is continuously integrally joined to one return length 159 of the oxygenator tube 151. The multiple return lengths 159 all terminate at substantially the same terminus line 186 level on the device 150. The multiple return length 159 extend downward inside the boundary case 157 adjacent to the interior case perimeter, each one of the tubes 159 having a tube exit terminus 163 disposed downward through the case wall. The tube lengths 159 are fluid imperviously sealed to the case wall. As schematically illustrated in FIG. 6, the inlet blood 160 is mixed in a two-phase flow with the inlet oxygen 161 and introduced into the multiple oxygenator tubes 151 at the base header plate 156. The oxygenated blood foam 162 exits from each one of the oxygenator tube.exit terminus 163. The filtered defoamed blood is formed by passage through the annular blood defoamer filter combination of the annular defoamer 165 and the cloth filter 167. The defoamed blood is held in the blood collection reservoir 172. The annular defoamer 165 is secured by a first foam filter tie ring 166, and further secured by the cloth filter 167 which is additionally secured by the second tie ring 168. The top of the foam filter 165 and cloth filter 167 combination are secured in position by the first top closure 169. The first closure 169 also forms the top terminus of the heat exchanger 187. Q
' The heat exchanger 187 can exchange energy with the blood foam disposed in the multiple oxygenator tubes The heat exchanger 187 comprises the multiple oxygenator tubes 151, the base header plate 156, the first closure 169, the exchanger tubular boundary case 157, the water inlet conduit 176, and the water outlet conduit 179. Thus operationally the heat transfer fluid, typically water, flows in the inlet flow direction 177 and flows out of the heat exchanger in the direction 181. The water outlet conduit 179 has an internal exchanger terminus 180.
As disclosed in the above referenced application, the device 150 has a second top closure 182, a reservoir bottom closure 184, and an external tubular case 183, as previously disclosed. The blood outlet flow 173 is through the blood outlet conduit 175. As disclosed above, the exchanged gases escape upward through the annular gas escape chamber 170 through the annular defoamer filter 165 and the cloth filter 167 into the annular aperture 174, and thence out of the device 150 through the second top closure 182 as previously taught. The oxygenator component device 150, as taught above provides a further modification of the blood foam retum exchanger device, having increased blood foam residence time in the oxygenator tubes'in a compact device occupying relatively a short space and volume in a surgical operating room environment.
F lG. 7 illu st rates in det ail therelative positions of the multiple return loops 158 disposed in the patterned tubular array 152, which can provide for the patterned disposition of the multiple return lengths 159 of each one of the tubes 151, adjacent to the interior perimeter of the case 157. As illustrated, the return lengths 159 are disposed in a circular array around the perimeter of the patterned tubular array 152. FIG. 6 illustrates in elevational view and FIG. 7 illustrates in cross sectional view the positioning of the tiers of the multiple return loops 158. The multiple tube exit terminus 163 are disposed exteriorly through the case 157.
By incorporating the blood foam return exchanger device of this invention in combination with an extracorporeal blood oxygenator and blood temperature controller disclosed, taught and claimed in the crossreferenced applications, it is possible to reduce the length, typically 73 or the like, of the array of the multiple oxygenator tubes 71 or the like, since the blood foam is provided additional residence time in the blood foam return exchanger device for gas exchange. Further, the blood exchanges energy with the heat transfer fluid, such as water, as the blood foam rises in the patterned tubular array 72 or the like, and then further exchanges thermal energy as the blood foam descends in the direction or the like in the blood foam return exchanger device. The additional residence time in the blood foam return exchanger device can provide blood foam counter flow for further precisely adjusting the blood foam temperature to the desired value, preventing fluctuation in blood temperature, which can be very undesirable. In those surgically selected cases where there is a requirement for induction of hypothermia, a metal fin structure can be incorporated in the blood foam return exchanger device as taught above, providing for a rapid controlled change of blood temperature, as is required. As a further advantage of this invention, the annular blood defoamer filter combination utilized with the invention filters from the bottom of the filter initially, rising toward the top of the filteras the filter pores become clogged. Thus the defoamed blood does not needlessly wash the unused filter until it is required. The filtered blood does not wet and stand in the unrequired annular foam filter. The filtering of the blood foam initially at the base of the annular foam filter provides additional safety against the introduction of minute quantities of compositions which can produce undesired responses in the patient.
In illustration of the performance of the invention, a 25 kg weight dog test animal was perfused approximately 91 minutes, utilizing the extra-corporeal blood oxygenator and blood temperature controller incorporating the blood foam return exchanger device illustrated in FIG. 2. Initially, the test animal was sedated with Nembutal and cannulae bypass were inserted into the heart aorta and right atrium. The oxygenator was initially primed with 1,000 ml of Ringers lactate. Additional Ringers lactate and blood were added as required during the perfusion test. The essential data measuring the status of the dog are listed in Table I. The test animal was successfully maintained on the oxygenator of this invention for minutes. Sustained pumped perfusion was maintained at. an (O vol./Blood vol) ratio ranging from a high of 3.33 down to 0.435. The successful perfusion at a ratio of 0.435 is particularly notable. The hemoglobin analysis of blood Samples l and 2 after 38 and 9l minutes on perfusion bypass indicate respective rates of hemoglobin mg percent of 0.97 and 0.48 mg percent/min. A rate of 1.0 mg percent/min is considered surgically acceptable. Two commercially available blood oxygenator devices have typical mg percent/min values of 1.3 and 2.5 respectively. v
Many modifications and variations in the improvement in the blood foam return exchanger device can be made in the light of our teaching. It is therefore understood that within the scope of the appended claims, the invention may be practiced otherwise than as specifically described.
1. In anextra-corporeal blood oxygenator and blood temperature controller having a patterned array of multiple, small diameter, equal length oxygenator tubes disposed in a top and a bottom pair of fluid-imperviousv header plates, useful for providing a blood foam composition in said multiple oxygenator tubes, the improvement comprising a blood foam return exchanger device combination comprising:
a tubular boundary case having a case interior, said base header plate, said top. header plate and said.
multiple oxygenator tubes secured in said case interior, in a fluid exchanger configuration; ameans having-multiple fluid flow guidance channels disposed adjacent the exterior of said tubular boundary case, providing guidance of said blood foam in a direction countercurrent to the flow of said blood foam in said multiple oxygenator tubes, said means having a return shell capterminus disposed a spaced holding chamber volume above said top header plate, said means havinga return shell length extending downwardly around andparallel to saidfluid exchanger configuration provid=- ing multiple bloodfoam exit terminuses ata predetermined distance below said top header plate, said means providinga residence completion time for blood oxygenationat a required bloodlflow rate. and blood temperature.
2. In an extra-corporeal blood oxygenator and bloodtemperature controller having a patterned array of multiple, small diameter, equal length oxygenator tubes disposed in a top and bottom pair of fluid-impervious header plates, wherein a blood foam composition can; be, formed in-said multiple oxygenator tubes, the. improvement comprising. a blood foam retum exchanger device combination comprising:
a tubular heat-exchangerboundary casehaving a.
case. interior, said, base header plate, said top' header plate and said multiple oxygenator tubes secured in said caseinterior in a fluid exchange configuration, said tubular case having multiplelfluid flow guidance fins linearly disposedton the exterior. ofsaidboundary case parallel to the casetubular axis of symmetry and. encirclingithe exterior case OXYGEN PERFUSlON TEST BLOOD OXYGEN ARTERIAL p02 pCO2 HGT 7002 FLOW FLOW pH (min) (min) Saturate TIME STATUS (l/min) (l/min) I 1001 Pro-pump 7.54 381 18 43 99+ 1030 Partial oxygenator L8 6 1032 Complete oxygenator 2.1 1035 lst arterialblood sample 2.1 5 7.66 355 I65 27 99 I035 lst venous blood sample 2.1 5 7.60 37 25.5 29 82 1056 2nd arterial sample 2.l 3 7.52 365 23 99 1056 2nd venous sample 2.1 3 7.46 37 30 28 7794 lll5 3rd arterial sample 2.l 3 7.55 371 20 24 99 1115 3rd venous sample 2.1 3 7.47 33 27 27 93.4 1 134 4tharterial sample 2.1 4 7.29 4H) 39 25 99 H34 4th venous sample 2.1 4 7.27 43 42 76.6 1150 5th arterial sample 2.l 2.35 7.25 377 43 27 99+ 1150 5th venous sample 2.1 2.35 7.23 45 48 28 72.4 I I59 6th arterial sample 2.3 l 7.2] 298 SI 27 99 I159 6th venous sample 2.3 l 7.18 56 57 28 8l l20l Off pump Used 95% 02 5% CO2 HEMOGLOBIN ANALYSIS Time on HEM HEM/Min Laboratory Sample BvDass (min) (nlg.%) (mg %/min) Sample 1 38 37.2 0.97
Sample 2 9] 43.6 0.48
Normal l.0
We claim: perimeter, said multiple guidance fins integrally secu'red to said exterior case perimeter and having fin lengths extending from said top header plate to multiple fin exit terminuses at a predetermined distance below said top header plate; and,
a return shell adjacently' fitting exteriorly around and over said multiple guidance fins, said return shell having a shell length providing multiple blood foam exit terminuses adjacent to said multiple fin exit terminuses, said return shell having a cap terminus disposed above a spaced holding chamber volume above said top header plate,
whereby said blood foam composition which can be formed in said multiple oxygenator tubes can flow into said spaced holding chamber volume, thence into the multiple fluid flow guidance channels provided between said return shell and said multiple fluid flow guidance fins and down through said multiple blood foam exit terminuses of said foam return fluid exchanger device.
3.- The blood foam return exchanger device of claim 2 in which said tubular heat exchanger boundary case is formed froma non-toxic metal having a thinorganic composition coating disposed completely over the faceofsaidcase'exposed to said blood foam, said coating' being physiologically compatible with said blood foam.
4'. The blood foam return exchanger device of claim 2 in-which saidretum shell is formed-from a plastic composition, physiologically .compatible with said blood foam.
The blood foam return exchanger device of claim 2 having an annular blood defoamer filter loosely temperaturecontroller having a patterned array of.
multiple-small diameter, equal length oxygenator tubes disposed ina top and a bottom pair of fluid-impervious header plates, providing a blood foam composition in said multiple oxygenator tubes, the improvement comprising a blood foam return exchanger device combination comprising:
a tubular heat exchanger boundary case having a case interior, said base header plate, said top header plate and said multiple oxygenator tubes secured in said case interior in a fluid exchanger configuration; and,
a tubular return shell adjacently fitting circumferentially around said fluid exchanger configuration, said return shell having multiple fluid flow guidance channels interiorly disposed on the tubular shell wall, said guidance channels disposed between adjacent pairs of fins integrally secured to said tubular shell parallel to the tubular axis of symmetry of said shell, said fins encirclingly disposed contiguous to the exterior of said tubular boundary case, said fins having fin lengths extending from at least said top header plate to multiple fin exit terminuses at a predetermined distance below said top header plate, said tubular return shell having a cap terminus disposed above a spaced holding chamber volume above said top header plate, said multiple fin lengthproviding a blood foam residence time between said fins for completion of blood oxygenation at a required blood flow rate and blood temperature.
7. The blood foam return exchanger device of claim 6 in which said tubular return shell is formed from a non-toxic metal having a thin organic composition coating disposed completely over the face of said shell exposed to said blood foam, said coating being physiologically compatible with said blood foam.
8. The blood foam return exchanger device of claim 6 in which said tubular return shell is formed from a plastic composition, physiologically compatible with said blood foam.
9. The blood foam return exchanger deviceof claim 6 having an annular blood defoamer filter loosely spaced completely circumferentially around said return changer tubular boundary case securing said header plate in the boundary case base, the improvement comprising a blood foam return exchanger device combination comprising:
said multiple oxygenator tubes having a controlled range of tube lengths, each one of said tubes having a U-bend at the upper extremity thereof, each one of said tubes having a return length extending downwardly inside said exchanger case adjacent to the interior perimeter of said case, each one of said tubes having a tube exit terminus disposed downwardly, through the exchanger case wall and fluid imperviously sealed to said wall, all said exit terminuses disposed at substantially the same terminus line level of said case; a closure securing the top of said heat exchanger case; means for conducting a heat transfer fluid through said heat exchanger case; an annular blood defoamer filter spaced circumferentially around said heat exchanger case and said multiple tube exit terminuses, said filter having one perimeter terminus conductively sealed to said exchanger case adjacently below said case closure, and said filter having the second perimeter terminus conductively sealed to said oxygenator below said terminus line level so that blood foam exiting from said multiple tube exit terminuses must pass through said defoamer filter.

Claims (9)

  1. 2. In an extra-corporeal blood oxygenator and blood temperature controller having a patterned array of multiple, small diameter, equal length oxygenator tubes disposed in a top and bottom pair of fluid-impervious header plates, wherein a blood foam composition can be formed in said multiple oxygenator tubes, the improvement comprising a blood foam return exchanger device combination comprising: a tubular heat exchanger boundary case having a case interior, said base header plate, said top header plate and said multiple oxygenator tubes secured in said case interior in a fluid exchange configuration, said tubular case having multiple fluid flow guidance fins linearly disposed on the exterior of said boundary case parallel to the case tubular axis of symmetry and encircling the exterior case perimeter, said multiple guidance fins integrally secured to said exterior case perimeter and having fin lengths extending from said top header plate to multiple fin exit terminuses at a predetermined distance below said top header plate; and, a return shell adjacently fitting exteriorly around and over said multiple guidance fins, said return shell having a shell length providing multiple blood foam exit terminuses adjacent to said multiple fin exit terminuses, said return shell having a cap terminus disposed above a spaced holding chamber volume above said top header plate, whereby said blood foam composition which can be formed in said multiple oxygenator tubes can flow into said spaced holding chamber volume, thence into the multiple fluid flow guidance channels provided between said return shell and said multiple fluid flow guidance fins and down through said multiple blood foam exit terminuses of said foam return fluid exchanger device.
  2. 3. The blood foam return exchanger device of claim 2 in which said tubular heat exchanger boundary case is formed from a non-toxic metal having a thin organic composition coating disposed completely over the face of said case exposed to said blood foam, said coating being physiologically compatible with said blood foam.
  3. 4. The blood foam return exchanger device of claim 2 in which said return shell is formed from a plastic composition, physiologically compatible with said blood foam.
  4. 5. The blood foam return exchanger device of claim 2 having an annular blood defoamer filter loosely spaced completely circumferentially around said return shell, said filter having one perimeter terminus secured to said tubular boundary case adjacently below said multiple fin exit terminuses, and said filter having a second perimeter terminus secured to said return shell adjacent to said return cap terminus.
  5. 6. In an extra-corporeal blood oxygenator and blood temperature controller having a patterned array of multiple small diameter, equal length oxygenator tubes disposed in a top and a bottom pair of fluid-impervious header plates, providing a blood foam composition in said multiple oxygenator tubes, the improvement comprising a blood foam return exchanger device combination comprising: a tubular heat exchanger boundary case having a case interior, said base header plate, said top header plate and said multiple oxygenator tubes secured in said case interior in a fluid exchanger configuratIon; and, a tubular return shell adjacently fitting circumferentially around said fluid exchanger configuration, said return shell having multiple fluid flow guidance channels interiorly disposed on the tubular shell wall, said guidance channels disposed between adjacent pairs of fins integrally secured to said tubular shell parallel to the tubular axis of symmetry of said shell, said fins encirclingly disposed contiguous to the exterior of said tubular boundary case, said fins having fin lengths extending from at least said top header plate to multiple fin exit terminuses at a predetermined distance below said top header plate, said tubular return shell having a cap terminus disposed above a spaced holding chamber volume above said top header plate, said multiple fin length providing a blood foam residence time between said fins for completion of blood oxygenation at a required blood flow rate and blood temperature.
  6. 7. The blood foam return exchanger device of claim 6 in which said tubular return shell is formed from a non-toxic metal having a thin organic composition coating disposed completely over the face of said shell exposed to said blood foam, said coating being physiologically compatible with said blood foam.
  7. 8. The blood foam return exchanger device of claim 6 in which said tubular return shell is formed from a plastic composition, physiologically compatible with said blood foam.
  8. 9. The blood foam return exchanger device of claim 6 having an annular blood defoamer filter loosely spaced completely circumferentially around said return shell, said filter having one perimeter terminus secured to said tubular boundary case adjacently below said multiple fin exit terminuses of said tubular return shell and said filter having a second perimeter terminus secured to said return shell adjacent said return cap terminus.
  9. 10. In an extra-corporeal blood oxygenator and blood temperature controller having a patterned array of small diameter oxygenator tubes disposed in a bottom fluid-impervious header plate, and a heat exchanger tubular boundary case securing said header plate in the boundary case base, the improvement comprising a blood foam return exchanger device combination comprising: said multiple oxygenator tubes having a controlled range of tube lengths, each one of said tubes having a 180* U-bend at the upper extremity thereof, each one of said tubes having a return length extending downwardly inside said exchanger case adjacent to the interior perimeter of said case, each one of said tubes having a tube exit terminus disposed downwardly, through the exchanger case wall and fluid imperviously sealed to said wall, all said exit terminuses disposed at substantially the same terminus line level of said case; a closure securing the top of said heat exchanger case; means for conducting a heat transfer fluid through said heat exchanger case; an annular blood defoamer filter spaced circumferentially around said heat exchanger case and said multiple tube exit terminuses, said filter having one perimeter terminus conductively sealed to said exchanger case adjacently below said case closure, and said filter having the second perimeter terminus conductively sealed to said oxygenator below said terminus line level so that blood foam exiting from said multiple tube exit terminuses must pass through said defoamer filter.
US00259713A 1972-06-05 1972-06-05 A bubble oxygenerator including a blood foam return exchanger device Expired - Lifetime US3807958A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US00259713A US3807958A (en) 1972-06-05 1972-06-05 A bubble oxygenerator including a blood foam return exchanger device

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US00259713A US3807958A (en) 1972-06-05 1972-06-05 A bubble oxygenerator including a blood foam return exchanger device

Publications (1)

Publication Number Publication Date
US3807958A true US3807958A (en) 1974-04-30

Family

ID=22986064

Family Applications (1)

Application Number Title Priority Date Filing Date
US00259713A Expired - Lifetime US3807958A (en) 1972-06-05 1972-06-05 A bubble oxygenerator including a blood foam return exchanger device

Country Status (1)

Country Link
US (1) US3807958A (en)

Cited By (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3941356A (en) * 1974-11-13 1976-03-02 The United States Of America As Represented By The Department Of Health, Education And Welfare Method and apparatus for continuous mixing of blood plasma and additives
DE2625366A1 (en) 1975-06-06 1976-12-16 Bentley Lab BLOOD OXYGENATION DEVICE
US4058369A (en) * 1974-01-28 1977-11-15 Bentley Laboratories, Inc. Oxygenator
US4177816A (en) * 1978-03-27 1979-12-11 Sci-Med Life Systems, Inc. Heat exchanger for blood
US4182739A (en) * 1976-02-03 1980-01-08 Shiley Incorporated Blood oxygenator
US4188360A (en) * 1978-09-08 1980-02-12 Japan Medical Supply Co., Ltd. Artificial lung with a built-in heat exchanger
FR2446642A1 (en) * 1979-01-16 1980-08-14 Baxter Travenol Lab APPARATUS FOR OXYGENING BLOOD
US4228125A (en) * 1978-06-20 1980-10-14 Cobe Laboratories, Inc. Gas exchange apparatus
US4231988A (en) * 1978-06-13 1980-11-04 Japan Medical Supply Co., Ltd. Artificial lung
US4248828A (en) * 1974-01-28 1981-02-03 Bentley Laboratories, Inc. Oxygenator
US4261951A (en) * 1978-03-02 1981-04-14 Dsd "Metalchim" Apparatus for blood oxygenation
US4280981A (en) * 1979-11-06 1981-07-28 C. R. Bard, Inc. Blood oxygenator
US4376095A (en) * 1980-08-25 1983-03-08 Terumo Corporation Hollow fiber-type artificial lung having enclosed heat exchanger
US4396584A (en) * 1981-06-01 1983-08-02 Mike Burgess Blood oxygenator
US4407777A (en) * 1981-07-22 1983-10-04 Wilkinson William R Blood oxygenator
US4568367A (en) * 1982-11-15 1986-02-04 Shiley Incorporated Blood defoamer with improved liquid seal
US4585056A (en) * 1984-04-18 1986-04-29 Norton Company Heat exchanger
US4637917A (en) * 1983-10-14 1987-01-20 Reed Charles C Bubble oxygenator
US4818566A (en) * 1986-05-16 1989-04-04 Elastogran Maschinenbau Gmbh Apparatus for mixing multicomponent plastics, in particular polyurethane
US5120501A (en) * 1988-10-20 1992-06-09 Baxter International Inc. Integrated membrane blood oxygenator/heat exchanger
US5225161A (en) * 1988-10-20 1993-07-06 Baxter International Inc. Integrated membrane blood oxygenator/heat exchanger
WO1998019721A1 (en) * 1996-11-07 1998-05-14 C.R. Bard, Inc. Integrated oxygenator and heat exchanger
US5762869A (en) * 1996-07-24 1998-06-09 Gish Biomedical, Inc. Blood oxygenator
USRE36774E (en) * 1989-10-01 2000-07-11 Baxter Healthcare Corporation Cylindrical blood heater/oxygenator
US20050077228A1 (en) * 2003-10-03 2005-04-14 Mri S.R.L. Societa Unipersonale Blood treatment machine and unit
US20060016743A1 (en) * 2004-07-23 2006-01-26 Terumo Kabushiki Kaisha Artificial lung
US20070166189A1 (en) * 2006-01-19 2007-07-19 Terumo Kabushiki Kaisha Oxygenator
US20070231203A1 (en) * 2006-03-28 2007-10-04 Terumo Kabushiki Kaisha Filter member and oxygenator using same
US20080243045A1 (en) * 2003-10-03 2008-10-02 Medical Service S.R.L Apparatus and method for the treatment of blood
US20090098017A1 (en) * 2007-10-16 2009-04-16 Board Of Regents, The University Of Texas System Nanoporous membrane exchanger
US20110082340A1 (en) * 2009-10-07 2011-04-07 Tyco Healthercare Group LP Foam collar for surgical access devices
JP2011161147A (en) * 2010-02-15 2011-08-25 Nipro Corp Heat exchanger-integrated artificial lung
CN102753211A (en) * 2010-02-15 2012-10-24 尼普洛株式会社 Heat exchanger and heat exchanger-integrated artificial lung
US8747742B2 (en) 2010-02-15 2014-06-10 Nipro Corporation Heat exchanger and heat-exchanger-integrated oxygenator
US11291754B2 (en) * 2016-03-11 2022-04-05 Rheinisch-Westfaelische Technische Hochschule (Rwth) Aachen System for the extracorporeal elimination of carbon monoxide

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3291568A (en) * 1964-04-06 1966-12-13 Richard D Santter Cardio-pulmonary by-pass oxygenator unit
US3488158A (en) * 1966-12-12 1970-01-06 Bentley Lab Bubbler assembly for oxygenator
US3493347A (en) * 1967-12-12 1970-02-03 Hazen F Everett Blood oxygenator
US3547591A (en) * 1968-10-16 1970-12-15 Jose C Torres Bubble film oxygenator
US3578411A (en) * 1969-07-22 1971-05-11 Bentley Lab Bubbler assembly for blood treating apparatus
US3615238A (en) * 1969-09-11 1971-10-26 Donald J Bentley Oxygenator
US3764271A (en) * 1972-01-10 1973-10-09 R Brumfield Blood oxygenator in combination with a low pressure heat exchanger
US3769163A (en) * 1971-11-08 1973-10-30 R Brumfield Blood oxygenator flow guide
US3769162A (en) * 1971-08-26 1973-10-30 R Brumfield Blood oxygenator and thermoregulator apparatus

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3291568A (en) * 1964-04-06 1966-12-13 Richard D Santter Cardio-pulmonary by-pass oxygenator unit
US3488158A (en) * 1966-12-12 1970-01-06 Bentley Lab Bubbler assembly for oxygenator
US3493347A (en) * 1967-12-12 1970-02-03 Hazen F Everett Blood oxygenator
US3547591A (en) * 1968-10-16 1970-12-15 Jose C Torres Bubble film oxygenator
US3578411A (en) * 1969-07-22 1971-05-11 Bentley Lab Bubbler assembly for blood treating apparatus
US3615238A (en) * 1969-09-11 1971-10-26 Donald J Bentley Oxygenator
US3769162A (en) * 1971-08-26 1973-10-30 R Brumfield Blood oxygenator and thermoregulator apparatus
US3769163A (en) * 1971-11-08 1973-10-30 R Brumfield Blood oxygenator flow guide
US3764271A (en) * 1972-01-10 1973-10-09 R Brumfield Blood oxygenator in combination with a low pressure heat exchanger

Cited By (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4248828A (en) * 1974-01-28 1981-02-03 Bentley Laboratories, Inc. Oxygenator
US4058369A (en) * 1974-01-28 1977-11-15 Bentley Laboratories, Inc. Oxygenator
US3941356A (en) * 1974-11-13 1976-03-02 The United States Of America As Represented By The Department Of Health, Education And Welfare Method and apparatus for continuous mixing of blood plasma and additives
DE2625366A1 (en) 1975-06-06 1976-12-16 Bentley Lab BLOOD OXYGENATION DEVICE
DE2661025A1 (en) * 1975-06-06 1985-08-14
US4182739A (en) * 1976-02-03 1980-01-08 Shiley Incorporated Blood oxygenator
US4261951A (en) * 1978-03-02 1981-04-14 Dsd "Metalchim" Apparatus for blood oxygenation
US4177816A (en) * 1978-03-27 1979-12-11 Sci-Med Life Systems, Inc. Heat exchanger for blood
US4231988A (en) * 1978-06-13 1980-11-04 Japan Medical Supply Co., Ltd. Artificial lung
US4228125A (en) * 1978-06-20 1980-10-14 Cobe Laboratories, Inc. Gas exchange apparatus
US4188360A (en) * 1978-09-08 1980-02-12 Japan Medical Supply Co., Ltd. Artificial lung with a built-in heat exchanger
FR2446642A1 (en) * 1979-01-16 1980-08-14 Baxter Travenol Lab APPARATUS FOR OXYGENING BLOOD
US4280981A (en) * 1979-11-06 1981-07-28 C. R. Bard, Inc. Blood oxygenator
US4376095A (en) * 1980-08-25 1983-03-08 Terumo Corporation Hollow fiber-type artificial lung having enclosed heat exchanger
EP0046583B1 (en) * 1980-08-25 1985-11-21 Terumo Corporation Hollow fiber-type artificial lung having enclosed heat exchanger
US4396584A (en) * 1981-06-01 1983-08-02 Mike Burgess Blood oxygenator
US4407777A (en) * 1981-07-22 1983-10-04 Wilkinson William R Blood oxygenator
US4568367A (en) * 1982-11-15 1986-02-04 Shiley Incorporated Blood defoamer with improved liquid seal
US4637917A (en) * 1983-10-14 1987-01-20 Reed Charles C Bubble oxygenator
US4585056A (en) * 1984-04-18 1986-04-29 Norton Company Heat exchanger
US4818566A (en) * 1986-05-16 1989-04-04 Elastogran Maschinenbau Gmbh Apparatus for mixing multicomponent plastics, in particular polyurethane
US5120501A (en) * 1988-10-20 1992-06-09 Baxter International Inc. Integrated membrane blood oxygenator/heat exchanger
US5225161A (en) * 1988-10-20 1993-07-06 Baxter International Inc. Integrated membrane blood oxygenator/heat exchanger
USRE36774E (en) * 1989-10-01 2000-07-11 Baxter Healthcare Corporation Cylindrical blood heater/oxygenator
US5762869A (en) * 1996-07-24 1998-06-09 Gish Biomedical, Inc. Blood oxygenator
US6001306A (en) * 1996-11-07 1999-12-14 C. R. Bard, Inc. Integrated oxygenator and heat exchanger
WO1998019721A1 (en) * 1996-11-07 1998-05-14 C.R. Bard, Inc. Integrated oxygenator and heat exchanger
US20080243045A1 (en) * 2003-10-03 2008-10-02 Medical Service S.R.L Apparatus and method for the treatment of blood
US20050077228A1 (en) * 2003-10-03 2005-04-14 Mri S.R.L. Societa Unipersonale Blood treatment machine and unit
US8070952B2 (en) 2003-10-03 2011-12-06 Medical Service S.R.L. Apparatus and method for the treatment of blood
US7947113B2 (en) 2004-07-23 2011-05-24 Terumo Kabushiki Kaisha Artificial lung
US20110186514A1 (en) * 2004-07-23 2011-08-04 Terumo Kabushiki Kaisha Artificial lung
US7431754B2 (en) * 2004-07-23 2008-10-07 Terumo Kabushiki Kaisha Artificial lung
US8142546B2 (en) 2004-07-23 2012-03-27 Terumo Kabushiki Kaisha Artificial lung
US20060016743A1 (en) * 2004-07-23 2006-01-26 Terumo Kabushiki Kaisha Artificial lung
US20090107898A1 (en) * 2004-07-23 2009-04-30 Terumo Kabushiki Kaisha Artificial lung
US8017075B2 (en) * 2006-01-19 2011-09-13 Terumo Kabushiki Kaisha Oxygenator
US8968652B2 (en) 2006-01-19 2015-03-03 Terumo Kabushiki Kaisha Oxygenator
US20070166189A1 (en) * 2006-01-19 2007-07-19 Terumo Kabushiki Kaisha Oxygenator
US9199025B2 (en) 2006-03-28 2015-12-01 Terumo Kabushiki Kaisha Filter member and oxygenator using same
US8911666B2 (en) 2006-03-28 2014-12-16 Terumo Kabushiki Kaisha Filter member and oxygenator using same
US20070231203A1 (en) * 2006-03-28 2007-10-04 Terumo Kabushiki Kaisha Filter member and oxygenator using same
US8425838B2 (en) * 2006-03-28 2013-04-23 Terumo Kabushiki Kaisha Filter member and oxygenator using same
US9522362B2 (en) 2006-03-28 2016-12-20 Terumo Kabushiki Kaisha Filter member and oxygenator using same
WO2009052316A3 (en) * 2007-10-16 2009-06-04 Univ Texas Nanoporous membrane exchanger
WO2009052316A2 (en) * 2007-10-16 2009-04-23 Board Of Regents, The University Of Texas System Nanoporous membrane exchanger
US20090098017A1 (en) * 2007-10-16 2009-04-16 Board Of Regents, The University Of Texas System Nanoporous membrane exchanger
US20110082340A1 (en) * 2009-10-07 2011-04-07 Tyco Healthercare Group LP Foam collar for surgical access devices
CN102753211A (en) * 2010-02-15 2012-10-24 尼普洛株式会社 Heat exchanger and heat exchanger-integrated artificial lung
US8747742B2 (en) 2010-02-15 2014-06-10 Nipro Corporation Heat exchanger and heat-exchanger-integrated oxygenator
JP2011161147A (en) * 2010-02-15 2011-08-25 Nipro Corp Heat exchanger-integrated artificial lung
CN102753211B (en) * 2010-02-15 2015-01-21 尼普洛株式会社 Heat exchanger and heat exchanger-integrated artificial lung
US11291754B2 (en) * 2016-03-11 2022-04-05 Rheinisch-Westfaelische Technische Hochschule (Rwth) Aachen System for the extracorporeal elimination of carbon monoxide

Similar Documents

Publication Publication Date Title
US3807958A (en) A bubble oxygenerator including a blood foam return exchanger device
US3768977A (en) Integral blood oxygenator and heat exchanger
US3769162A (en) Blood oxygenator and thermoregulator apparatus
US4138464A (en) Blood oxygenator with integral heat exchanger
US4902476A (en) Heat exchanger and blood oxygenator apparatus
US4138288A (en) Method and apparatus for oxygenating and regulating the temperature of blood
US4282180A (en) Blood oxygenator
EP0378168B1 (en) Artificial lung assembly
JP7393327B2 (en) Dual chamber gas exchanger for breathing assistance and how to use it
US5312589A (en) Gas transfer apparatus
JPS5843105B2 (en) Extracorporeal blood circuit device
US4067696A (en) Blood oxygenator
US3764271A (en) Blood oxygenator in combination with a low pressure heat exchanger
JPH0622620B2 (en) Integrated blood membrane oxygenator / heat exchanger
JPH0374586B2 (en)
US3769163A (en) Blood oxygenator flow guide
US4585056A (en) Heat exchanger
US4183961A (en) Method of oxygenating blood
CA1213488A (en) Blood oxygenator heat exchanger
CN113509605B (en) Membrane oxygenator
US4336224A (en) Bubble oxygenator
US4280981A (en) Blood oxygenator
US4637917A (en) Bubble oxygenator
IE49063B1 (en) Bubble oxygenator
CA1145634A (en) Blood oxygenator with integral heat exchanger